The Scientific World Journal / 2012 / Article / Tab 1

Research Article

Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18F-Fluoride PET/CT Bone Scans

Table 1

Clinically significant extraosseous findings on CT of 18F-fluoride PET/CT.

Patient no.Age (y)SexType of cancerIncidental findings by unenhanced CT

154 FBreast cancerChest wall recurrence
246 FBreast cancerPulmonary metastases
371 FBreast cancerPulmonary metastases
434 FBreast cancerAxillary metastatic lymph nodes
568 FBreast cancerPulmonary metastases and axillary metastatic lymph nodes
634 FBreast cancerAxillary metastatic lymph nodes
747 FBreast cancerAxillary metastatic lymph nodes
850 FBreast cancerPulmonary metastases
961 FHepatocellular carcinomaPulmonary metastases
1068 MHepatocellular carcinomaPulmonary metastases
1150 MHepatocellular carcinomaPulmonary metastases
1248 MHepatocellular carcinomaPulmonary and adrenal metastases
1351 MBuccal cancerCervical metastatic lymph nodes
1470 FColon cancerPulmonary metastases
1559 FEndometrical cancerPrimary breast cancer with axillary metastatic lymph nodes
1636 FOvarian cancerMetastatic tumor of abdominal wall
Tongue cancer
Primary lung cancer with ipsilateral pulmonary metastases

PET: positron emission tomography; CT: computed tomography.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.